Rubius Therapeutics, Inc.

OTCPK:RUBY Rapporto sulle azioni

Cap. di mercato: US$5.2m

Rubius Therapeutics Gestione

Gestione criteri di controllo 0/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Craig Jalbert

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOless than a year
Proprietà del CEOn/a
Durata media del managementNessun dato
Durata media del Consiglio di amministrazione2.7yrs

Aggiornamenti recenti sulla gestione

Recent updates

Rubius Therapeutics GAAP EPS of -$0.49 beats by $0.03

Aug 09

Rubius: Poor Data, Punishing Environment, Beaten Stock

Jun 19

Rubius Looks Attractive Before AACR Data Readout

Mar 21

Are Rubius Therapeutics, Inc. (NASDAQ:RUBY) Investors Paying Above The Intrinsic Value?

Oct 28
Are Rubius Therapeutics, Inc. (NASDAQ:RUBY) Investors Paying Above The Intrinsic Value?

Our Read On Rubius Therapeutics

Jul 11

Rubius Therapeutics EPS beats by $0.02

May 10

Have Insiders Been Buying Rubius Therapeutics, Inc. (NASDAQ:RUBY) Shares?

Feb 25
Have Insiders Been Buying Rubius Therapeutics, Inc. (NASDAQ:RUBY) Shares?

Rubius Therapeutics (RUBY) Presents At 39th Annual Healthcare Conference - Slideshow

Jan 14

Rubius Therapeutics EPS misses by $0.01

Nov 09

Rubius Therapeutics' RTX-321 shows dual mechanism of action in HPV-positive cancers

Oct 28

AMMINISTRATORE DELEGATO

Craig Jalbert (61 yo)

less than a year

Mandato

Mr. Craig R. Jalbert, CIRA, serves as President, Corporate Secretary, Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer at Evelo Biosciences, Inc. since November 21,...

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Craig Jalbert
Presidentless than a yearNessun datoNessun dato
Michael Rosenblatt
Independent Director9.1yrsUS$421.66kNessun dato
Robert Langer
Member of Scientific Advisory Board9.1yrsUS$850.74kNessun dato
Harvey Lodish
Scientific Advisory Board5.9yrsUS$24.00kNessun dato
Gerald Nepom
Member of Scientific Advisory Board2.7yrsNessun datoNessun dato
Vijay Kuchroo
Member of Scientific Advisory Board2.7yrsNessun datoNessun dato
Susanne Schaffert
Director1.5yrsNessun datoNessun dato
Francis Cuss
Independent Director6yrsUS$426.66kNessun dato
Christopher Carpenter
Member of Scientific Advisory Board4yrsUS$2.84mNessun dato
Christopher Hunter
Member of Scientific Advisory Board2.7yrsNessun datoNessun dato
John Monroe
Member of Scientific Advisory Board2.7yrsNessun datoNessun dato

2.7yrs

Durata media

68yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di RUBY non è considerato esperto (durata media del mandato 2.7 anni), il che suggerisce un nuovo consiglio.